Mascoma Wealth Management’s Blackstone BX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2K Hold
87
﹤0.01% 322
2026
Q1
$10K Buy
87
+10
+13% +$1.3K ﹤0.01% 321
2025
Q4
$11.9K Buy
77
+11
+17% +$1.67K ﹤0.01% 303
2025
Q3
$11.3K Hold
66
﹤0.01% 317
2025
Q2
$9.87K Hold
66
﹤0.01% 323
2025
Q1
$9.22K Hold
66
﹤0.01% 339
2024
Q4
$11.4K Hold
66
﹤0.01% 335
2024
Q3
$10.1K Hold
66
﹤0.01% 327
2024
Q2
$8.17K Hold
66
﹤0.01% 354
2024
Q1
$8.67K Hold
66
﹤0.01% 331
2023
Q4
$8.64K Hold
66
﹤0.01% 332
2023
Q3
$7.07K Hold
66
﹤0.01% 355
2023
Q2
$6.85K Sell
66
-344
-84% -$29.7K ﹤0.01% 357
2023
Q1
$36.6K Sell
410
-60
-13% -$5.3K 0.01% 267
2022
Q4
$34.9K Hold
470
0.01% 274
2022
Q3
$39K Hold
470
0.01% 260
2022
Q2
$43K Hold
470
0.01% 258
2022
Q1
$60K Hold
470
0.02% 239
2021
Q4
$61K Hold
470
0.02% 203
2021
Q3
$55K Buy
+470
New +$54.5K 0.02% 192
2021
Q2
Sell
-410
Closed -$31K 152
2021
Q1
$31K Buy
+410
New +$28.3K 0.01% 256

Other funds holding BX

Mascoma Wealth Management's BX Position: Q2 2026 in Review

Mascoma Wealth Management held its Blackstone (BX) position steady in Q2 2026 at 87 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

Mascoma Wealth Management first reported a position in BX in Q1 2021 and has held it in 21 quarters since. The position peaked at $61K in Q4 2021. 2,144 funds tracked by Wall St. Rank hold BX as of Q2 2026.

  • Mascoma Wealth Management held 87 shares of Blackstone worth $10.2K as of Q2 2026.
  • Mascoma Wealth Management left its Blackstone share count unchanged in Q2 2026.
  • Blackstone made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #322 holding.
  • Mascoma Wealth Management first reported a position in Blackstone in Q1 2021 and has held it in 21 quarters since.
  • Mascoma Wealth Management's Blackstone position peaked at $61K in Q4 2021.
  • 2,144 funds tracked by Wall St. Rank held Blackstone as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.